chrisvoncsefalvay/vaers-outcomes huggingface dataset:
left leg had muscle pain; foot was numb/tingling; right side of her face and upper body was tingling; This is a spontaneous report from a contactable nurse (patient). A 35-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 intramuscular, administered in arm right on 13Feb2021 10:30 (Lot number was not reported) as single dose for covid-19 immunisation. Medical history included covid-19, seasonal allergy and allergy to some fruits. Patient was not pregnant at the time of vaccination. No prior vaccinations within 4 weeks. Concomitant medication(s) included zinc (ZINC), fish oil, cyanocobalamin (VIT B12) and vitamin d. The patient previously took metamucil and experienced allergy. On 13Feb2021 16:00, (evening), patient was laying on her right side in bed for maybe an hour and the right side of her face and upper body was tingling like it "fell asleep". On 16Feb2021, 3 days later she got to work at 3pm and her left leg had muscle pain and foot was numb/tingling. The tingling lasted about an hour. Muscle pain still persisted although not as bad. Treatment was not received for the events. Patient was diagnosed with COVID-19 prior to vaccination and has not been tested post-vaccination. Outcome of the event muscle pain was not recovered, for event foot was numb was recovered while for the remaining event was unknown.  Information on the lot/batch number has been requested.
Hospitalized for BKA then transferred to another hospital. Found to have asymptomatic Covid infection.
A few days after receiving the injection, subject started complaining about feeling like he has a lump in his throat. Now a week past and he still has the same sensation. Difficulty swallowing.
Patient is a 81 y.o. female with history of COPD/emphysema on oxygen at home who presents with shortness of breath, chest pain, and nausea.  She states her symptoms started this past Thursday.  They progressively worsened with time.  She normally wears 2 L of oxygen at home at night at baseline.  However, her oxygen needs have had to increased since this past Thursday and she was up to 10 L oxygen at home today prior to coming to the emergency department.  She came to the emergency department on Saturday 08/21/2021 and was positive for COVID-19.  She did not require any more oxygen to be admitted at that time.  She did have her COVID-19 vaccine and was fully vaccinated well over a month ago.  She denies any other complaints today.  Of note, she states only 1 of her lungs is working at 100% as the other 1 is being collapse by an uneven diaphragm.  She had a car accident recently and had a ruptured sternum with diaphragmatic rupture. Hospital Course: Patient was treated for COVID-19 protocol.  Unfortunately, her respiratory status continued to decompensate.  She began telling staff that she was ?done ?and ?ready to go to the lord.?  After difficult discussion, patient elected to make herself comfort measures only.  Aggressive measures were discontinued and her family was allowed to visit say goodbye.  She passed away 08/29/2021 at 1007.  May she rest in peace.
Localized 5 inch area of redness, induration surrounding DTaP injection site left forearm. No fever. From shoulder. No adenopathy. Will observe.
Within 2 hours after receiving flu shot, patient felt red bumps that were abrasive to touch on her skin. She is not allergic to eggs. Last flu shot 10 yrs ago. Next day she had red spots all over her body that itched. She was taking Benadryl. No respiratory problems.
Pt has a history of cerebral palsy and presents with evaluation of hypoxia with increased needs for trach suctioning. Pt found to have COVID pneumonia.
Systemic: skin Rash- dryness similar to eczema-Mild, Additional Details: Pt called and described getting spotting similar to how eczema looks with no prior history of eczema.  Spots gets itchy when dry.
Mother states fever 103 yesterday 6/29/06. Mother instructed to call Pediatrician for F/U. no redness, swelling at injection.
pt recvd vax; w/in 2days was found to be HASAG pos;antigenemia
Patient states that she woke up this morning with redness and extensive swelling to left arm, with hives and itching.
pt recv vax 4MAR96 & 1OCT97 pt exp a breakthrough mild case chickenpox;
noted inc urination, thirst, lethargy & weight loss for 1 wk prior to talking to MD; blood sugar 508 @ clinic on 27DEC94; adm to hosp & treated w/insulin; Is now insulin dependent diabetes;
Case number PHEH2013US005049, is an initial spontaneous report received from a nurse on 27 FEB 2013. This report refers to a 28-year-old female patient. Her medical history and concomitant medications was not reported. On 02 JAN 2013, she was vaccinated with MENVEO, batch number: M12009) which was inadvertently stored at an unknown temperature above 46F for 4.75 hours on 03 DEC 2012. No adverse event was reported following this administration error.
Back began mildly itching by late evening on 5/13.  In the morning when I woke, my back was wet where a blister had developed and popped.   The blister was about the size of a 50 cent piece.  It continued oozing until about noon.  I could see some welts had developed but could not see all of my back.
Nurse called and reported vaccination to patient with improperly stored vaccine; No additional adverse events reported.; This spontaneous report was received from a registered nurse, referring to a patient of unknown age and gender. The patients' pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported.   On an unknown date, the patient was vaccinated with an improperly stored of rotavirus vaccine, live, oral, pentavalent (ROTATEQ), administered at a dose of 2 milliliters (ml), by oral route (formulation, strength, vaccination scheme, lot number and expiration date were not reported) as prophylaxis. The vaccine administered experienced a temperature of 28 degrees Fahrenheit (F), 33.9F, 50.2F, for a time frame of 7 hours and 10 minutes. There was no previous temperature excursion reported. The report did not involved the data logger. No additional adverse events were reported.   This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2009USA009446: US-009507513-2009USA009631: US-009507513-2009USA009674:
This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 71-year-old female patient who received Shingrix for prophylaxis. In April 2018, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, 1 day after receiving Shingrix, the patient experienced influenza-like symptoms, swelling arm and fever. On an unknown date, the outcome of the influenza-like symptoms, swelling arm and fever were recovered/resolved. The reporter considered the influenza-like symptoms, swelling arm and fever to be probably related to Shingrix. Additional information was reported as follows: The patient received Shingrix in the left deltoid. After vaccination with Shingrix, the patient experienced swelling of the arm that lasted for 4 to 5 days. She had a low grade fever. The patient had denied permission to contact her physician.
Facial swelling and rash, started day after vaccination on 9/1/21 and has progressively become worse resulting in provider visit. As of 10/4 patient has completed prednisone 20mg daily for 5 days. Symptoms temporarily improved but have returned. Hydroxyzine helps improve facial swelling but some days has to pry open eyes.
While putting child into car leaving the appt. she spaced out, her eyes were glazed over. Within 20 minutes of noticing the first problems her fever spiked up. When fever spiked the doctor was called and staff encouraged close observation of the child and Tylenol.
103 degree fever, headache, fatigue, muscle and joint pain, injection site pain, chills, fever, and nausea. Developed symptoms starting at about noon the day after vaccination and progressively got worse throughout the afternoon and evening. Symptoms made it impossible to conduct normal activities but have mostly resolved in the second day.
This non-valid, spontaneous report was received from a registered nurse, referring to an unspecified number of patients of unknown age and gender. No information was provided regarding the patients' medical history, previous drug reactions, allergies, concurrent medical conditions or concomitant medications. On unknown dates, the patients were vaccinated with improperly stored doses of LIQUID PEDVAXHIB lot number N034005 (expiration date 31-JAN-2020) and lot number reported as "N021920" (expiration date 07-FEB-2020) for prophylaxis (doses, routes and anatomical locations of administration were not reported). Additionally, the patients were vaccinated with ROTATEQ by oral route, lot number N005078 (expiration dates 22-NOV-2018 and 04-OCT-2018) for propylaxis (doses were unknown), GARDASIL 9 lot number N020352 (expiration date 10-APR-2020) for prophylaxis (doses, routes and anatomical locations of administration were not provided) and M-M-R II for prophylaxis (dose numbers, routes and anatomical locations of administration were not provided; lot numbers N010496 [expiration date 31-MAR-2019], N014485 [expiration date 10-MAY-2019], and N023149 [expiration date 24-AUG-2019]). The vaccines were reconstituted with sterile diluent which was reported to be properly stored. The doses of all vaccines were exposed to a temperature excursion below 32 degrees Fahrenheit (F) (also reported as 31F) during a time frame of 15 days, which was detected by the Digital Data Logger. There was no prior temperature excursion and no adverse effects were reported. Follow-up information was received from the nurse on 17-DEC-2018. The reporter provided patients' demographics which made the case valid. This report refers to a 11-year-old patient of unknown gender. On 21-FEB-2018, the patient was vaccinated with an improperly stored dose of GARDASIL 9 lot number N020352 (expiration date 10-APR-2020). This is one of multiple reports received from the same reporter.; Sender's Comments: US-009507513-1807USA011661:
Noticed at 3pm on 5/09/13 there was a bump on right arm where injection was. Went to go touch it and my daughter cried, this is quite a solid bump, and very painful. I attempted to apply a warm compress but she was not going to let me due to the pain. She has never had a reaction before.
Cough started as a tickle in throat, became so bad she could not breathe only breath was between coughs, took her to the ER.
20 Minutes after  I get the shots I have numbness on the right side of the face. The following day I have dropping on the right side of the face.  7 days later the symptoms came back worst and I was Advice by Doctor to go to ER to rule out stroke. I spend 2 days in the Hospital, every thing came back negative for stroke. I did follow up with my regular doctor and neurologist.  I continue to have numbness in on the right side of my face and my tonged and pressure in my head. I register in V-safe but no one called me. I also try CDC but no results.   I HAVE A 3,000 Hospital bill .
On day 8 developed itchy, red and warm to touch  area approx size in width of approximately golf ball round area just below the injection site.   Arm felt heavy but not tender to touch.  Had a slight bruise above where injection site went. Nothing prior to day 8 though.  I also was very tired all day, chills, and seemed to bring out  dry slightly itchy bumpy rosacea  on my cheeks.  I had no fever . Red started Friday and Saturday and resolved by Sunday 2/14
Moderate Diarrhea lasting ~4 hours, mild nausea, 102.7 fever, mild headache, sever joint & muscle pain, sever foot pain in sides of feet, severe sensitivity to touch, all beginning~11:00pm day of injection and subsiding ~24 hours later. With mild to Moderate joint pain persisting for an additional 24 hours.  Moderate head pressure and Moderate dizziness starting upon waking up 3/27/2021, requiring setting medical attention with medication being prescribed,  and symptoms have not eased at this time.
Sever body aches, fever, lethargy, fatigue, sever headache, pain at the injection sight, elevated heart rate.
62 yo female /w no rxn to 1st dose of Hep B- 2nd dose of Hep B vax Mar91, developed a drop in her Hgb which the MD characterized as hemolytic anemia. Pt developed myalgia,arthralgia & inc creatinine. 5Mar91 hospitalized for experience.
Rec'd vaccine at 1:30 pm on 02/03/21.  Next morning, diarrhea, fever, and was unable to stand up, even with aid of a walker and my husband's help. Muscle weakness, which  lasted about  24 hours. . After 24 hours, took 2 Tylenol,  Next day problem was gone. And no further problem with muscle weakness. Did read CDC recommendations, not to take 2nd dose if there were problems. And I will not be t aking the second one on 03-03021. Did call Health Dept and reported it but not sure what staff member I visited with, but it was not the nurse who gave injection nor the Administrator.
Feeling sickly, flushed, nausea and vomiting, full body shaking tightness in chest 2 epi pens (0.6 mg) and 50mg Diphenhydramine PCR protocol-then Ambulance arrived on scene. Medical record states dyspnea.msv Medical record states allergic reaction. msv
2 swollen lymphnodes on left neck and 1 on right neck. After blood work December and again in May (with a chest X-ray), results came back inconclusive and was concluded to be a result of vaccination. LAD still present today. Lymph nodes seemingly more reactive to illness than ever before. 10/26/2009 records from multiple MD visits. Patient with c/o's swollen  cervical lymph nodes, noted since 9/2008. PE: noted multiple rt and lt sided subcentimeter nodules that were mobile and non-tender. No tx noted, patient to return if any enlargement or change in nodules is noted.
Pt received vaccine on 1/31/22.  Vaccine was taken out of freezer on 12/30/21, therefore expired on 1/29/2022.
Patient called next day to report that she is not feeling good, has shivers, chills, fever, and requested appropriate agency to reduce vaccine dose.
I write today because On January 20, I received my first Pfizer covid vaccination. I have felt no side effects but when I read the story of the doctor who died of bleeding after that vaccination, I became concerned because I do get minor petechiae from the blood thinner and then yesterday (1/25) I noticed a petechiae different from the rest. It was on my back and was bigger than the few tiny pinpoint ones from the medication.  I am wondering if the vaccine made the difference and if my platelet count is going down. Is it possible that the vaccine might interact with blood thinners and create Thrombocytopenia? I have never heard of that disease before, but I think it can exist unknown or maybe be started by the vaccine. I will be watching for any additional petechiae, but would it be good to get a platelet test to see if something has gone wrong? The doctor with zero platelets, no symptoms and death by bleeding has caused me concern and if blood thinners, my eczema or undiagnosed Thrombocytopenia cause issues for vaccines, that information would be good to know. I am a 76 year old male in generally good health. My fitbit walking target is at least 4 miles/day and I usually reach that. At 5? 9? and 172 pounds I enjoy golf weekly when winter is over. Two issues do exist. Twenty seven months ago while searching for the cause of some PVCs the doctors put in a stent and scarred a diagonal artery causing what they said was a heart attack. Recovery was quick and subsequent tests indicate the heart was healed and working fine. I have no heart symptoms, but since then have been on first Brillinta and now Clopidorgrel (Plavix) plus baby aspirin. Second, last August I was diagnosed with eczema which might be psoriasis which I think is autoimmune related.  It is annoying at times but the prescription cream helps.
4x6 reddened, sl swollen, tender area @ inj site l deltoid;
6-7 hours after shot was given, parent called stating that child has 103 fever and swollen fontanelle. Patient went to Emergency room where was evaluated by MD. Was offered a spinal tap but refused, was told by physician that she saw similar cases after immunizations (not specification on type of vaccine) and child was discharged.
I experienced a sore arm at first, with redness, which then grew in size, to about 3 inches in diameter. The pain and swelling, along with itchiness were unbearable. I also developed respiratory symptoms: cough, congestion and an ear infection. I was concerned enough to get a COVID 19 test, which was negative. The symptoms did not not subside until almost 3 weeks after the 1st dose.
This solicited pregnancy report received from a consumer concerned a male neonate of unspecified race and ethnicity. The patient was enrolled in a non-company sponsored study. The patient's weight at birth was 3.49 kilograms (7 pounds and 11 ounces), and height at birth was 19 inches and at the time of report weight was 13 pounds and 10 ounces, body length was 21 inches. The patient's pre-existing medical conditions included: The patient had no birth defects; genetic or inherited disorders have been diagnosed since birth. The patient-initiated treatment with covid-19 vaccine (dose number in series was 1) (suspension for injection, transplacental, batch number: 1805018, expiry: UNKNOWN) dose was not reported, 1 total, administered on 24-MAR-2021 for covid-19 immunisation. Concomitant medications included ascorbic acid/betacarotene/calcium sulfate/colecalciferol/cyanocobalamin/ferrous fumarate/folic acid/nicotinamide/pyridoxine hydrochloride/retinol acetate/riboflavin/thiamine mononitrate/tocopheryl acetate/zinc oxide for drug used for unknown indication. On an unspecified date in 2021, Laboratory data were performed: Acoustic stimulation tests (NR: not provided) baby passed the hearing test, and Cardiac function test (NR: not provided) baby's heart was fine (dose number in series 1). On 24-MAR-2021, the patient experienced foetal exposure during pregnancy (coded as drug exposure in utero). On 10-SEP-2021, Laboratory data included: SARS-CoV-2 test (NR: not provided) Negative. On 15-SEP-2021, the patient was admitted into hospital and the reason for hospitalisation was not specified. The patient spent two days in the hospital. Laboratory data included: SARS-CoV-2 test (NR: not provided) Negative (dose number in series 1). The action taken with covid-19 vaccine was not applicable. The outcome of the foetal exposure during pregnancy and hospitalisation was not reported. The reporter considered the causality between covid-19 vaccine, and hospitalisation as unassessable. The reporter did not provide a causality assessment between covid-19 vaccine, and foetal exposure during pregnancy. Company causality between covid-19 vaccine, and hospitalisation was related, and between covid-19 vaccine, and foetal exposure during pregnancy was not related.  This report was serious (Hospitalization Caused / Prolonged). This parent/child case is linked to 20210753294.; Sender's Comments: V0: 20211260896-COVID-19 VACCINE hospitalisation. This event(s) is considered related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20211260896-COVID-19 VACCINE foetal exposure during pregnancy . This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS.
Patient had a stroke that began the morning of 3/14/21 around 10 AM.  He was in the bathroom at the time by himself and fell as he became disoriented as a result of the stroke.  His diagnosis on 3/15  was "intraparenchymal cerebellar hemorrhage with intraventricular extension".    Right-sided 7.0 French triple lumen IJ central venous catheter placement under ultrasound guidance was completed on 3/15 as well.
Fever of 101 for 12 hours Skin sensitivity: painful to touch, constant needles  Shortness of breath  Difficulty to move without getting winded Muscle aches all over except for at injection site for 5 days  Three weeks later: I am still feeling needles in my back, I still have shortness of breath, anxiety, period like spotting before period is due, sudden chills, and stiffness in muscles that was not there prior to vaccine.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63-year-old male patient received BNT162b2 (BNT162B2), on 13Mar2021 at 09:00 as dose 1, single (Lot number: EN6257), in left arm, on 10Apr2021 at 10:00 as dose 2, single (Lot number: EW0153), in left arm and on 21Dec2021 at 10:00 as dose 3 (booster), single (Lot number: 331308A) at the age of 63 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "hypertension" (unspecified if ongoing); "Known allergy: Peanuts" (unspecified if ongoing). Concomitant medication(s) included: VASCEPA; MICARDIS; HYDROXYZINE; VERAPAMIL; FLOVENT HFA.  The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative; Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19.
Pt developed tenderness, induration, erythema of left arm where vaccine placed; also swelling of left hand, neck, head pain and hoarseness, 1 hour after receiving vaccine.
Pt vaccinated with DTP/OPV developed high fever in 5 hrs; Febrile seizure within 14 hrs.
vaccine that had experienced a temperature excursion was given as 1st dose; vaccine that had experienced a temperature excursion was given as 1st dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT STORAGE ERROR (vaccine that had experienced a temperature excursion was given as 1st dose) and EXPIRED PRODUCT ADMINISTERED (vaccine that had experienced a temperature excursion was given as 1st dose) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Sep-2021, the patient experienced PRODUCT STORAGE ERROR (vaccine that had experienced a temperature excursion was given as 1st dose). On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine that had experienced a temperature excursion was given as 1st dose). At the time of the report, PRODUCT STORAGE ERROR (vaccine that had experienced a temperature excursion was given as 1st dose) and EXPIRED PRODUCT ADMINISTERED (vaccine that had experienced a temperature excursion was given as 1st dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided. No treatment medication was provided.